Hot stock: Biosensors surges more than 20% on Citic's offer to buy rest of company
THE share price of Biosensors International Group, a maker of coronary stents, surged more than 20 per cent on Wednesday morning following the news that a private-equity arm of Citic Group Corp has agreed to buy the rest of the Singapore-listed company for about S$1.1 billion.
After hitting S$0.82 a share, Biosensors was trading around S$0.81, up 13 cents, or 19 per cent, at 11:40am. More than 17 million shares changed hands.
Citic Private Equity Funds Management Co, which already controls about 19.6 per cent of Biosensors, is paying S$0.84 a share for the stock it doesn't already own, according to a stock exchange statement on Wednesday. The price is about 24 per cent higher than Biosensors' last closing price of S$0.68.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Capital Markets & Currencies
Hong Kong Stock Exchange bids farewell to first woman chair
Asia stocks rise on Wednesday amid Wall Street rally; STI up 0.6%
Brokerage Haitong removes long-term Hong Kong unit chief Lin, appoints new head
Asia: Stocks rise on earnings optimism as US data approaches
Singapore stocks climb at Wednesday’s open; STI up 0.4%
Stocks to watch: MPACT, CapitaLand Ascott Trust, Hotel Properties, OUE Reit, CLCT